Reason: Failed Tablet/Capsule Specifications; Product contains broken tablets.
Distributed: Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.Reason: Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
Distributed: NationwideReason: Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
Distributed: NationwideReason: Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used to treat edema, making it an unapproved new drug
Distributed: Nationwide, Hawaii and Puerto RicoReason: Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
Distributed: Nationwide, Puerto Rico, Jamaica, and Grenada.Reason: Microbial Contamination of Non-Sterile Product(s): The product was found to be contaminated with Bulkholderia sp.
Distributed: NationwideReason: Marketed Without An Approved NDA/ANDA: FDA analysis found eXtenZone which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved b
Distributed: CAReason: Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved
Distributed: CAReason: Marketed Without An Approved NDA/ANDA: FDA analysis found Rhino 5 which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved by
Distributed: CAReason: Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.
Distributed: Nationwide and Puerto Rico